Invocation Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 3 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 251.23%
- Profit Growth 1201.46%
- Ebitda 184.07%
- Net Worth 16.58%
- Total Assets 61.82%
About Invocation Pharmaceuticals
Invocation Pharmaceuticals Private Limited (IPPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 July 2021 (Three years and six months 26 days old ). Its registered office is in Jaipur, Rajasthan, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Ashu Gupta and Meenu Joshi serve as directors at the Company.
Company Details
-
Location
Jaipur, Rajasthan, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24290RJ2021PTC075909
-
Company No.
075909
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Jul 2021
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Invocation Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashu Gupta
|
Director | 15-Jul-2021 | Current |
|
Meenu Joshi
|
Director | 15-Jul-2021 | Current |
Financial Performance of Invocation Pharmaceuticals.
Invocation Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 251.23% increase. The company also saw a substantial improvement in profitability, with a 1201.46% increase in profit. The company's net worth Soared by an impressive increase of 16.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Invocation Pharmaceuticals?
Unlock access to Invocation Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Durg Engineering Ventures Private LimitedAshu Gupta is a mutual person
-
Transhind Overseas Consultants Private LimitedAshu Gupta is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Invocation Pharmaceuticals?
Invocation Pharmaceuticals has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Invocation Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Invocation Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.